Biotechnology/Chemical/Pharmaceutical Customer Partnership  

Tuesday, April 17th, 2001
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Academy Room 1, Crystal Square 4, 7th Floor

 

Morning Session
9:00 – 9:30 AM Opening Remarks Jasemine Chambers
John Doll
Directors TC 1600
9:30 – 10:10 AM The Electronic Filing System (421K)

Mary Small, Search and Information Resources Administration (SIRA)

10:10 – 10:30 AM Break
10:30 – 10:50 AM New Amendment Format, (36K) and TC 1600 Customer Service Center  (565K) Helen Childs/Margaret Stevens, Head Supervisory Legal Instruments Examiners, TC 1600
10:50 – 11:20 AM  Pre-Grant Publications (1,020K) Hiram Bernstein, Legal Advisor, Office of Patent Legal Administration
11:20 - 11:30 AM Closing Remarks (morning session)
11:30 AM to 1:00PM Lunch 
Afternoon Session
1:00 - 1:10 Introductory Remarks
1:10 – 1:45 PM  Chemical Claim Language/Red Flag Terms (79K) Joseph McKane, Supervisory Patent Examiner, TC 1600
1:45 – 2:20 PM Pharmaceutical Compositions and Enablement (62K) Robert Hill, Quality Assurance Specialist, TC 1600
2:20 – 2:40 PM  Break
2:40 – 3:15 PM Examination Practice in the Single Nucleotide Polymorphisms (SNP) Art (699K) Gary Jones, Supervisory Patent Examiner, TC 1600
3:15 – 3:50 PM Sequence Homology and Prediction of Function (458K) James Martinell, Senior Level Examiner, TC 1600
3:50 – 4:00 PM Closing Remarks Jasemine Chambers
John Doll
Directors TC 1600